Frontlight ResearchEarly access
Trial site
Ichikawa
- 3closed trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers1 trial
- Chronic myeloid leukaemia1 trial
- Multiple sclerosis1 trial
- Polymyalgia rheumatica1 trial
- Phase
- Phase 31 trial
- Status
- Completed3 trials
- Lead sponsor
- Novartis Pharmaceuticals3 trials
Closed trials
Completed
Completed
Completed
Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen
Site data: ClinicalTrials.govUpdated 15 Nov 2026